MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 67 filers reported holding MARINUS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is 0.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $18,000 | -63.3% | 11,931 | +0.8% | 0.00% | – |
| Q2 2019 | $49,000 | -99.5% | 11,841 | -98.9% | 0.00% | -100.0% |
| Q3 2018 | $10,334,000 | +994.7% | 1,033,326 | +673.8% | 0.01% | +800.0% |
| Q2 2018 | $944,000 | +237.1% | 133,546 | +263.9% | 0.00% | – |
| Q4 2015 | $280,000 | -66.1% | 36,695 | -62.9% | 0.00% | -100.0% |
| Q3 2015 | $826,000 | +227.8% | 99,015 | +355.3% | 0.00% | – |
| Q2 2015 | $252,000 | – | 21,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 6,502,840 | $13,201,000 | 3.58% |
| Lion Point Capital, LP | 6,374,740 | $12,940,000 | 3.42% |
| Granite Point Capital Management, L.P. | 1,889,100 | $3,835,000 | 2.17% |
| Bain Capital Life Sciences Investors, LLC | 5,942,735 | $12,064,000 | 2.04% |
| Asymmetry Capital Management, L.P. | 855,318 | $1,736,000 | 1.90% |
| ACUTA CAPITAL PARTNERS, LLC | 1,038,000 | $2,107,000 | 1.02% |
| Bleichroeder LP | 1,250,000 | $2,538,000 | 0.66% |
| Boxer Capital, LLC | 4,800,000 | $9,744,000 | 0.66% |
| Avoro Capital Advisors LLC | 6,200,000 | $12,586,000 | 0.42% |
| Islet Management, LP | 1,000,000 | $2,030,000 | 0.30% |